NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/19/2026
Back to search
Official data from USPTO
RENASCOR CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
RENASCOR CLINICAL RESEARCH
ST13
US500000098933956Class
42
Filing
98933956
Registration
8266638
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
05/19/2026
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
01/02/2025
Registration date
05/19/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2026
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/22/2025
First use in commerce
09/22/2025
Drawing code
4
Owner type
03
Owner location
RENO, NV, US
Examiner
FLEBBE, KEVIN ROBERT
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
R. R. (pessoa física)
Representatives
Kerry Eaton Eaton Law, PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/28/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/28/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/28/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/27/2026
IUAF
USE AMENDMENT FILED
11/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/18/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/18/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/26/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/23/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/29/2025
PUBO
PUBLISHED FOR OPPOSITION
07/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
06/24/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/24/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
06/24/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/24/2025
DOCK
ASSIGNED TO EXAMINER
06/13/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/28/2025
NWAP
NEW APPLICATION ENTERED
01/02/2025
Continuous trademark protection
Get notified about every new filing that threatens RENASCOR CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.